OUR PRODUCTS

MOBILE APPS

GENERAL INFO

Help

AKBA

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Akebia Therapeutics (AKBA) Earnings Date & Reports

Akebia Therapeutics Inc is a fully integrated biopharmaceutical company... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

AKBA is expected to report earnings to fall 166.67% to -1 cents per share on July 31

Akebia Therapeutics AKBA Stock Earnings Reports

Q2'25

Est.

$-0.02

Q1'25

Beat

by $0.08

Q4'24

Missed

by $0.03

Q3'24

Missed

by $0.04

Q2'24

Beat

by $0.03

The last earnings report on May 08 showed earnings per share of 2 cents, beating the estimate of -5 cents. With 5.72M shares outstanding, the current market capitalization sits at 971.75M.

View a ticker or compare two or three

Compare

AKBA

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For AKBA
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

View to see Real Time Patterns for AKBA (Try 14 days for Free)

A.I. Advisor

published General Information

General Information

a developer of drugs for the treatment of anemia and vascular diseases

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

245 First Street

Phone

+1 617 871-2098

Employees

167

Web

https://www.akebia.com